»ï¼º¼¿ïº´¿ø 2023 Kore-Japan Joint Symposium on Gene therapy in Inborn Errors of Immunity : 2023-02-25±³À°ÀÏÀÚ : 2023-02-25
±³À°Àå¼Ò : »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø B2 Áß°ÀÇÀå
±³À°ÁÖÁ¦ :
2023 Kore-Japan Joint Symposium on Gene therapy in Inborn Errors of Immunity ÁÖÃÖ±â°ü : »ï¼º¼¿ïº´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¼Ò¾Æû¼Ò³â°ú
´ã´çÀÚ : ¼ÛÁöÇý
¿¬¶ôó : 02-2148-7316
À̸ÞÀÏ :
smcpidoffice@naver.com ±³À°Á¾·ù : ÀÇ»çÇÐ
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 5 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 02-25 »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø B2 Áß°ÀÇÀå 09:50~10:00 Opening Remark Yae-Jean Kim(Samsung Medical Center, Sungkyunkwan University, Korea)
±âŸ 02-25 »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø B2 Áß°ÀÇÀå 10:00~10:10 Introduction on gene therapy in Inborn Errors of Immunity Yae-Jean Kim(Samsung Medical Center, Sungkyunkwan University, Korea)
±³À°½Ã°£ 02-25 »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø B2 Áß°ÀÇÀå 10:10~10:50 The first gene therapu in Japan: a long-term follow-up study of ADA (-) severe combined immunodeficiency paitens terated by retrovirs-stem cell gene therapy Makoto Otsu(Kitasato University, Japan)
ÈÞ½Ä 02-25 »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø B2 Áß°ÀÇÀå 10:50~11:00 Break ()
±³À°½Ã°£ 02-25 »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø B2 Áß°ÀÇÀå 11:00~11:20 Genetic epidemiology of chronic granulomatous disease in Korea Yae-Jean Kim(Samsung Medical Center, Sungkyunkwan University, Korea)
±³À°½Ã°£ 02-25 »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø B2 Áß°ÀÇÀå 11:20~12:00 Gene therapy for chronic granulomatous diseasa in Japan Masafumi Onodera(National Center for child Health and Development, Japan)
±³À°½Ã°£ 02-25 »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø B2 Áß°ÀÇÀå 12:00~12:30 Retinal gene therapy : Current perspective Sang Jin Kim(Samsung Medical Center, Sungkyunkwan University, Korea)
½Ä»ç 02-25 »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø B2 Áß°ÀÇÀå 12:30~13:30 Lunch time ()
±³À°½Ã°£ 02-25 »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø B2 Áß°ÀÇÀå 13:30~14:00 Gene therapy in Duchenne musular dystrophy and spinal muscualr atrophy Jee Hun Lee(Samsung Medical Center, Sungkyunkwan University, Korea)
±³À°½Ã°£ 02-25 »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø B2 Áß°ÀÇÀå 14:00~14:30 Overview of the lentiviral vector system for ex-vivo gene therapy Yeon-Soo Kim(Chugnam National University, Korea)
±³À°½Ã°£ 02-25 »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø B2 Áß°ÀÇÀå 14:30~15:10 Experience of gene therapy clinical trial for Wiskoot-Aldrich syundrome in Japan Toru Uchiyama(National Center for child Health and Development, Japan)
±³À°½Ã°£ 02-25 »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø B2 Áß°ÀÇÀå 15:10~15:30 Development of gene therapy for Inborn Errors of Immunity using targeted genome editing Toru Uchiyama(National Center for child Health and Development, Japan)
ÈÞ½Ä 02-25 »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø B2 Áß°ÀÇÀå 15:30~15:40 Break ()
±³À°½Ã°£ 02-25 »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø B2 Áß°ÀÇÀå 15:40~16:10 Gene therapeutics based on ribozy-mediated RNA replacement/editing strategy Seong-Wook Lee(Dankook University, RZnomics, Korea)
±³À°½Ã°£ 02-25 »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø B2 Áß°ÀÇÀå 16:10~16:50 Safety and efficacy evaluation for gene therapy produxts Masafumi Onodera(National Center for child Health and Development, Japan)
±âŸ 02-25 »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø B2 Áß°ÀÇÀå 16:50~17:50 Closing remark Jee Hun Lee(Samsung Medical Center, Sungkyunkwan University, Korea)